137 related articles for article (PubMed ID: 38363828)
1. A Test to Comprehensively Capture the Known Genetic Component of Familial Pulmonary Fibrosis.
Villeneuve J; Tremblay É; Gaudreault N; Saavedra Armero V; Boudreau DK; Li Z; Renaut S; Dion G; Bossé Y
Am J Respir Cell Mol Biol; 2024 Jun; 70(6):437-445. PubMed ID: 38363828
[TBL] [Abstract][Full Text] [Related]
2. A common MUC5B promoter polymorphism and pulmonary fibrosis.
Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA
N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741
[TBL] [Abstract][Full Text] [Related]
3. Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias.
van der Vis JJ; Snetselaar R; Kazemier KM; ten Klooster L; Grutters JC; van Moorsel CH
Respirology; 2016 May; 21(4):712-7. PubMed ID: 26699835
[TBL] [Abstract][Full Text] [Related]
4.
Mathai SK; Humphries S; Kropski JA; Blackwell TS; Powers J; Walts AD; Markin C; Woodward J; Chung JH; Brown KK; Steele MP; Loyd JE; Schwarz MI; Fingerlin T; Yang IV; Lynch DA; Schwartz DA
Thorax; 2019 Dec; 74(12):1131-1139. PubMed ID: 31558622
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment.
Biondini D; Cocconcelli E; Bernardinello N; Lorenzoni G; Rigobello C; Lococo S; Castelli G; Baraldo S; Cosio MG; Gregori D; Saetta M; Balestro E; Spagnolo P
Respir Res; 2021 Apr; 22(1):98. PubMed ID: 33794872
[TBL] [Abstract][Full Text] [Related]
6. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL
Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356
[TBL] [Abstract][Full Text] [Related]
7. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.
Stock CJ; Sato H; Fonseca C; Banya WA; Molyneaux PL; Adamali H; Russell AM; Denton CP; Abraham DJ; Hansell DM; Nicholson AG; Maher TM; Wells AU; Lindahl GE; Renzoni EA
Thorax; 2013 May; 68(5):436-41. PubMed ID: 23321605
[TBL] [Abstract][Full Text] [Related]
8. Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.
Moore C; Blumhagen RZ; Yang IV; Walts A; Powers J; Walker T; Bishop M; Russell P; Vestal B; Cardwell J; Markin CR; Mathai SK; Schwarz MI; Steele MP; Lee J; Brown KK; Loyd JE; Crapo JD; Silverman EK; Cho MH; James JA; Guthridge JM; Cogan JD; Kropski JA; Swigris JJ; Bair C; Kim DS; Ji W; Kim H; Song JW; Maier LA; Pacheco KA; Hirani N; Poon AS; Li F; Jenkins RG; Braybrooke R; Saini G; Maher TM; Molyneaux PL; Saunders P; Zhang Y; Gibson KF; Kass DJ; Rojas M; Sembrat J; Wolters PJ; Collard HR; Sundy JS; O'Riordan T; Strek ME; Noth I; Ma SF; Porteous MK; Kreider ME; Patel NB; Inoue Y; Hirose M; Arai T; Akagawa S; Eickelberg O; Fernandez IE; Behr J; Mogulkoc N; Corte TJ; Glaspole I; Tomassetti S; Ravaglia C; Poletti V; Crestani B; Borie R; Kannengiesser C; Parfrey H; Fiddler C; Rassl D; Molina-Molina M; Machahua C; Worboys AM; Gudmundsson G; Isaksson HJ; Lederer DJ; Podolanczuk AJ; Montesi SB; Bendstrup E; Danchel V; Selman M; Pardo A; Henry MT; Keane MP; Doran P; Vašáková M; Sterclova M; Ryerson CJ; Wilcox PG; Okamoto T; Furusawa H; Miyazaki Y; Laurent G; Baltic S; Prele C; Moodley Y; Shea BS; Ohta K; Suzukawa M; Narumoto O; Nathan SD; Venuto DC; Woldehanna ML; Kokturk N; de Andrade JA; Luckhardt T; Kulkarni T; Bonella F; Donnelly SC; McElroy A; Armstong ME; Aranda A; Carbone RG; Puppo F; Beckman KB; Nickerson DA; Fingerlin TE; Schwartz DA
Am J Respir Crit Care Med; 2019 Jul; 200(2):199-208. PubMed ID: 31034279
[No Abstract] [Full Text] [Related]
9. Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis.
Jiang H; Hu Y; Shang L; Li Y; Yang L; Chen Y
Int J Clin Exp Pathol; 2015; 8(11):14953-8. PubMed ID: 26823827
[TBL] [Abstract][Full Text] [Related]
10. Whole-exome sequencing identifies susceptibility genes and pathways for idiopathic pulmonary fibrosis in the Chinese population.
Fang C; Huang H; Feng Y; Zhang Q; Wang N; Jing X; Guo J; Ferianc M; Xu Z
Sci Rep; 2021 Jan; 11(1):1443. PubMed ID: 33446833
[TBL] [Abstract][Full Text] [Related]
11. MUC5B Promoter Variant rs35705950 Affects MUC5B Expression in the Distal Airways in Idiopathic Pulmonary Fibrosis.
Nakano Y; Yang IV; Walts AD; Watson AM; Helling BA; Fletcher AA; Lara AR; Schwarz MI; Evans CM; Schwartz DA
Am J Respir Crit Care Med; 2016 Feb; 193(4):464-6. PubMed ID: 26871673
[No Abstract] [Full Text] [Related]
12. Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways.
Schwartz DA
Ann Am Thorac Soc; 2018 Nov; 15(Suppl 3):S192-S197. PubMed ID: 30431344
[TBL] [Abstract][Full Text] [Related]
13. MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis.
van der Vis JJ; Prasse A; Renzoni EA; Stock CJW; Caliskan C; Maher TM; Bonella F; Borie R; Crestani B; Petrek M; Wuyts WA; Wind AE; Molyneaux PL; Grutters JC; van Moorsel CHM
Respirology; 2023 May; 28(5):455-464. PubMed ID: 36571111
[TBL] [Abstract][Full Text] [Related]
14. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis.
Horimasu Y; Ohshimo S; Bonella F; Tanaka S; Ishikawa N; Hattori N; Kohno N; Guzman J; Costabel U
Respirology; 2015 Apr; 20(3):439-44. PubMed ID: 25581455
[TBL] [Abstract][Full Text] [Related]
15. Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis.
Johnson C; Rosen P; Lloyd T; Horton M; Christopher-Stine L; Oddis CV; Mammen AL; Danoff SK
Respir Med; 2017 Sep; 130():52-54. PubMed ID: 29206633
[TBL] [Abstract][Full Text] [Related]
16. MUC5B and Idiopathic Pulmonary Fibrosis.
Yang IV; Fingerlin TE; Evans CM; Schwarz MI; Schwartz DA
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S193-9. PubMed ID: 26595739
[TBL] [Abstract][Full Text] [Related]
17. Familial forms of nonspecific interstitial pneumonia/idiopathic pulmonary fibrosis: clinical course and genetic background.
Borie R; Kannengiesser C; Crestani B
Curr Opin Pulm Med; 2012 Sep; 18(5):455-61. PubMed ID: 22781209
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary fibrosis in the era of stratified medicine.
Mathai SK; Newton CA; Schwartz DA; Garcia CK
Thorax; 2016 Dec; 71(12):1154-1160. PubMed ID: 27799632
[TBL] [Abstract][Full Text] [Related]
19. Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease.
Adegunsoye A; Vij R; Noth I
Chest; 2019 May; 155(5):1026-1040. PubMed ID: 30660786
[TBL] [Abstract][Full Text] [Related]
20. The minor T allele of the MUC5B promoter rs35705950 associated with susceptibility to idiopathic pulmonary fibrosis: a meta-analysis.
Wu X; Li W; Luo Z; Chen Y
Sci Rep; 2021 Dec; 11(1):24007. PubMed ID: 34907291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
